1.2 Tennessee Legal Architecture & Statutory Hierarchy

1.2 Tennessee Legal Architecture & Statutory Hierarchy

Pharmacy jurisprudence in the United States operates under a dual-sovereignty system established by the United States Constitution. The federal government derives its regulatory authority over pharmaceuticals primarily from the Interstate Commerce Clause (Article I, Section 8), creating uniform national standards for drug safety, efficacy, labeling, and controlled substance distribution. Simultaneously, the Tenth Amendment reserves general police powers to the states, empowering state governments to protect the health, safety, and welfare of their citizens through the regulation and licensure of professional occupations. In Tennessee, this authority is exercised through statutes enacted by the Tennessee General Assembly and administrative rules promulgated by the Tennessee Board of Pharmacy.

---

1. The Legal Hierarchy Pyramid

To correctly analyze legal questions on the Tennessee MPJE, candidates must visualize pharmacy law as an authoritative pyramid. Higher-level legal authorities supersede conflicting lower-level authorities, while subordinate authorities may refine, interpret, and enforce superior mandates:

                      ▲
                     / \
                    /   \
                   /  1  \     United States Constitution (Supreme Law of the Land)
                  /───────\
                 /    2    \    Federal Statutes (FDCA, CSA, PPPA, HIPAA - U.S. Code)
                /───────────\
               /      3      \   Federal Regulations (21 CFR Food & Drugs, 45 CFR)
              /───────────────\
             /        4        \  Tennessee Constitution
            /───────────────────\
           /          5          \ Tennessee Code Annotated (TCA Title 63 & Title 53)
          /───────────────────────\
         /            6            \ TN Board of Pharmacy Rules (TN Admin Code Ch 1140)
        /───────────────────────────\
       /              7              \ Local Ordinances & Professional Practice Standards
      └───────────────────────────────┘

Breakdown of Authority Levels

Statutes vs. Administrative Rules: Statutes are enacted directly by elected legislators in the Tennessee General Assembly and codified in the Tennessee Code Annotated (TCA). Administrative Rules are promulgated by the Tennessee Board of Pharmacy under express statutory authority delegated by the legislature (TCA § 63-10-308(c), which directs the Board to promulgate rules on minimum standards for pharmacy operation, the practice of pharmacy, professional conduct, and the receiving, preparing, maintaining, transferring, and dispensing of prescription orders). Administrative rules fill in operational details and possess the full force and effect of law. A violation of a Board of Pharmacy rule constitutes grounds for professional discipline, license suspension, or civil monetary penalties.

---

2. Resolving Legal Conflicts: The Stricter Law Rule & Anti-Preemption

Under Article VI, Clause 2 of the United States Constitution (the Supremacy Clause), valid federal law preempts (overrides) state law when the two conflict. There are three recognized forms of preemption:

1. Express Preemption: Congress explicitly includes statutory language barring state regulation (e.g., medical device premarket approvals under the FDCA).
2. Field Preemption: Federal regulation is so comprehensive that Congress leaves no room for states to supplement it.
3. Conflict Preemption: Occurs when compliance with both federal and state laws is physically impossible, or state law stands as an obstacle to accomplishing the full purposes and objectives of Congress.

The Controlled Substances Act (CSA) Anti-Preemption Provision

Crucially, Section 708 of the federal Controlled Substances Act (21 U.S.C. § 903) contains an explicit anti-preemption clause: Congress declared that federal controlled substance statutes do not occupy the field or displace state regulation unless there is a positive conflict between federal and state law such that the two cannot consistently stand together.

Because a licensee can comply with a state law that is more restrictive than federal law without violating federal law, more stringent state pharmacy laws do not create a positive conflict and are fully constitutional and enforceable.

The Operational Rule: Stricter Law Always Controls

This doctrine yields the single most important operational rule tested on the MPJE:

The Stricter Law Rule: Whenever federal law and Tennessee state law address the same subject matter, transaction, drug, or clinical scenario, the pharmacist, intern, technician, and pharmacy practice site must always adhere to the stricter, more stringent, or more restrictive law.

Adhering to the stricter standard inherently satisfies the less demanding standard, guaranteeing complete legal compliance across both federal and state jurisdictions.

What Makes a Law "Stricter" in Pharmacy Practice?

A statute or administrative rule is legally considered stricter if it:

• Imposes Shorter Timeframes or Earlier Expirations: Limits how long an order remains valid (e.g., Tennessee Together limiting acute pain opioid prescriptions to 3 days vs. federal law establishing no day-supply ceiling).
• Caps Quantities or Refills More Severely: Prohibits refills, sets lower dosage limits, or restricts transaction quantities (e.g., Tennessee capping pseudoephedrine sales at 7.2 g per 30 consecutive days vs. federal 9.0 g per 30 days).
• Mandates Additional Verification or Affirmative Actions: Requires checking the state Controlled Substance Monitoring Database (CSMD) prior to dispensing, obtaining ICD-10 diagnosis codes, or making a mandatory verbal offer to counsel on all new prescriptions.
• Demands Enhanced Physical Security or Documentation: Mandates tamper-resistant security features on all written prescriptions, or requires electronic serial tracking.
• Classifies a Substance into a More Restrictive Schedule: Treats a non-controlled federal substance as a monitored or controlled drug (e.g., Tennessee requiring Gabapentin dispensing to be reported to the CSMD as if it were a Schedule V controlled substance).

Clinical and Operational Comparisons: Federal vs. Tennessee Law

---

3. Key Tennessee Statutory Pillars: Title 63 vs. Title 53

Tennessee pharmacy statutes are codified in two primary titles of the Tennessee Code Annotated (TCA). Understanding the statutory boundary between Title 63 and Title 53 is essential for identifying the legal source of administrative authority:

┌─────────────────────────────────────────────────────────────────────────────┐
│                     TENNESSEE PHARMACY STATUTORY PILLARS                    │
├──────────────────────────────────────┬──────────────────────────────────────┤
│ TCA Title 63: Professions of the    │ TCA Title 53: Food, Drugs & Cosmetics │
│ Healing Arts                         │                                      │
├──────────────────────────────────────┼──────────────────────────────────────┤
│ • Chapter 10: Pharmacy Practice Act  │ • Chapter 10: Legend Drugs           │
│   - Part 2: Practice & Scopes        │   - Part 1: General Provisions & TRP │
│   - Part 3: Board of Pharmacy        │   - Part 2: Generic Substitution     │
│   - Part 4: Peer Review Committees   │   - Part 3: CSMD Advisory & Database │
│   - Part 5: Charitable Clinics       │ • Chapter 11: Controlled Substances  │
│ • Chapter 1: General Healing Arts    │   - Part 3: Dispensing Standards     │
│   - TCA § 63-1-164: TN Together      │   - Part 311: Prescription Caps      │
└──────────────────────────────────────┴──────────────────────────────────────┘

TCA Title 63, Chapter 10: The Tennessee Pharmacy Practice Act of 1996

Title 63 governs licensed healthcare professionals in Tennessee. Chapter 10 specifically governs the practice of pharmacy:

• Part 2 (Pharmacy Practice): Enacts foundational statutory definitions (TCA § 63-10-204), licensure standards for pharmacists and specialists (TCA § 63-10-205), prescription recordkeeping standards (TCA § 63-10-206), and Collaborative Pharmacy Practice Agreements (TCA § 63-10-217).
• Part 3 (Board of Pharmacy): Establishes the creation, powers, and duties of the Tennessee Board of Pharmacy (TCA § 63-10-301 through 63-10-308). Outlines Board composition: seven (7) members appointed by the Governor, consisting of six (6) licensed pharmacists (who must have been actively engaged in pharmacy practice in Tennessee for at least 5 years) and one (1) consumer member (a non-pharmacist public representative). Members serve 6-year terms. The Board possesses plenary authority to inspect practice sites, conduct investigations, issue subpoenas, suspend or revoke licenses, and levy civil penalties up to $1,000 per violation day.
• Part 4 (Peer Review Committees): Enacts comprehensive legal protections (TCA § 63-10-401 to 63-10-405) for peer review committees established by pharmacy associations, pharmacy schools, or healthcare facilities to investigate clinical errors and evaluate professional competence. Peer review proceedings are strictly privileged and confidential, immune from discovery, and committee members enjoy statutory civil immunity.
• Part 5 (Charitable Clinic Pharmacies): Authorizes charitable clinic pharmacies to dispense legend drugs to indigent and uninsured patients and receive donated prescription drugs under Board oversight.

TCA Title 53, Chapters 10 and 11: Legend Drugs & Controlled Substances

Title 53 regulates consumable goods, drugs, and controlled substances:

• Chapter 10 (Legend Drugs):
  • Part 1 (General Provisions): Prohibits unauthorized possession, sale, or distribution of legend drugs; establishes criminal penalties; and under TCA § 53-10-401, mandates that all written outpatient prescriptions issued by Tennessee prescribers must be executed on tamper-resistant prescription paper containing a latent void pattern, chemical-protection features, and security watermarks.
  • Part 2 (Prescription Drugs & Generic Substitution): Governs prescription labeling and under TCA § 53-10-204, establishes Tennessee's generic drug substitution law. Pharmacists must substitute a lower-cost therapeutically equivalent generic drug (FDA Orange Book "A" rating) unless the prescriber expressly writes in their own handwriting "dispense as written", "medically necessary", or "brand medically necessary".
  • Part 3 (Controlled Substance Monitoring Database): Codifies the Tennessee Controlled Substance Monitoring Database Act (TCA § 53-10-301 et seq.). Governs electronic database reporting (mandatory transmission of all Schedules II–V and Gabapentin dispensed by close of business the next business day) and mandates prescribers and dispensers query the CSMD prior to prescribing or dispensing opioids or benzodiazepines.
• Chapter 11 (Controlled Substances): Enacts the Tennessee Drug Control Act, defining controlled substance schedules, registration of manufacturers and distributors, inspection authority, and criminal forfeiture. Crucially, TCA § 53-11-311 and TCA § 63-1-164 codify the prescription limitations of the Tennessee Together opioid initiative.

---

4. Rules of the Tennessee Board of Pharmacy (Chapter 1140)

Under TCA § 63-10-308(c) and § 63-10-315, the Tennessee Board of Pharmacy is empowered to promulgate administrative regulations that govern the day-to-day operations of pharmacies and licensees. These rules are codified under Title 1140 of the Tennessee Administrative Code:

┌─────────────────────────────────────────────────────────────────────────────┐
│            TENNESSEE BOARD OF PHARMACY RULES (RULES CHAPTER 1140)           │
├──────────────┬──────────────────────────────────────────────────────────────┤
│ Chapter      │ Regulatory Scope & Core Provisions                          │
├──────────────┼──────────────────────────────────────────────────────────────┤
│ **1140-01**  │ Licensing & Registration: Pharmacist licensure; biennial    │
│              │ renewal; 30 hrs CE (15 live); intern & technician registration│
├──────────────┼──────────────────────────────────────────────────────────────┤
│ **1140-02**  │ Professional Conduct & Ethics: Mandatory verbal counseling   │
│              │ offer; patient profiles; DUR; technician ratio (6:1 / CPhTs) │
├──────────────┼──────────────────────────────────────────────────────────────┤
│ **1140-03**  │ Practice Site Standards: Physical specifications (180 sq ft);│
│              │ hot/cold water; refrigeration (2–8°C); security lockouts     │
├──────────────┼──────────────────────────────────────────────────────────────┤
│ **1140-04**  │ Institutional Practice Sites: Hospital pharmacies; emergency │
│              │ kits; after-hours access protocols; PIC responsibilities     │
├──────────────┼──────────────────────────────────────────────────────────────┤
│ **1140-05**  │ Continuing Education: Provider approval; audit procedures;   │
│              │ waiver criteria; CE retention requirements (2 years)         │
├──────────────┼──────────────────────────────────────────────────────────────┤
│ **1140-06**  │ Sterile Compounding: Incorporation of USP <797> and <800>;   │
│              │ cleanroom air quality (ISO classes); sterile documentation   │
├──────────────┼──────────────────────────────────────────────────────────────┤
│ **1140-07**  │ Non-Sterile Compounding: Incorporation of USP <795>; Master  │
│              │ Formulation Records; Compounding Records; BUD limits         │
├──────────────┼──────────────────────────────────────────────────────────────┤
│ **1140-14**  │ Collaborative Pharmacy Practice: Scope of CPPAs; protocol    │
│              │ requirements; $1M liability coverage; biennial reviews       │
└──────────────┴──────────────────────────────────────────────────────────────┘

---

5. Critical Statutory Definitions under TCA § 63-10-204

The Tennessee Pharmacy Practice Act of 1996 sets forth statutory definitions that define the boundaries of lawful practice. Questions on the MPJE frequently turn on these exact definitions:

1. Practice of Pharmacy (TCA § 63-10-204)

The statutory "practice of pharmacy" is defined broadly as a patient-oriented health service that includes, but is not limited to:

• Interpretation, evaluation, and implementation of medical orders and prescription drug orders;
• Dispensing of prescription drug orders;
• Participation in drug and device selection;
• Drug administration (e.g., immunizations pursuant to protocol);
• Drug regimen reviews (prospective and retrospective DUR);
• Drug or drug-related research;
• Provision of patient counseling and pharmaceutical care services;
• Compounding and labeling of drugs and devices;
• Proper and safe storage of drugs and devices and maintenance of proper records; and
• Performance of collaborative pharmacy practice in accordance with signed agreements.

2. Direct Supervision (TCA § 63-10-204)

"Direct supervision" means supervision by a licensed pharmacist who is physically present in the pharmacy practice site and personally oversees, directs, and inspects the activities of pharmacy interns, pharmacy technicians, and other supportive personnel.

Exam Significance: Technicians and interns cannot compound, reconstitute, or dispense medication when a pharmacist is not physically present in the prescription department, unless specifically operating within an authorized telepharmacy or satellite model expressly approved by the Board.

3. Institutional Facility (TCA § 63-10-204)

"Institutional facility" means any organization whose primary purpose is to provide a physical environment for patients to obtain healthcare services, including but not limited to: a hospital, convalescent home, nursing home, extended care facility, mental health facility, rehabilitation center, developmental disability facility, or correctional facility.

Exam Significance: Institutional facilities operate under Board Rule Chapter 1140-04, permitting distinct drug distribution mechanisms (such as floor stock, automated dispensing cabinets, emergency kits, and emergency after-hours access) that are strictly prohibited in community practice sites.

4. Legend Drug (TCA § 63-10-204)

"Legend drug" means any item of federal or state food, drug, and cosmetic law requiring a prescription order under 21 U.S.C. § 353(b) or bearing the federal legend "Rx only", or any drug restricted to use by authorized prescribing practitioners only.

5. Peer Review Committee (TCA § 63-10-204 & TCA § 63-10-401)

"Peer review committee" means any committee formed by a state or local professional pharmacy association, a school or college of pharmacy, or the pharmacy staff of a licensed healthcare institution, whose purpose is to evaluate the quality, efficiency, and appropriateness of pharmaceutical care services and determine the competence and conduct of pharmacists.

Statutory Protections (TCA § 63-10-401 through § 63-10-405):

• Absolute Confidentiality: All proceedings, records, minutes, witness statements, and communications of a peer review committee are strictly confidential and privileged.
• Immunity from Discovery: Peer review materials are not subject to subpoena or discovery in any civil lawsuit, medical malpractice action, or administrative proceeding against a pharmacist or pharmacy.
• Civil Immunity for Members: Committee members who act in good faith, without malice, and in the reasonable belief that their actions are warranted are completely immune from civil liability for monetary damages arising from their committee evaluations.

6. Pharmaceutical Care (TCA § 63-10-204)

"Pharmaceutical care" means the responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient's quality of life. These definite outcomes include:

1. Cure of a disease;
2. Elimination or reduction of a patient's symptomatology;
3. Arresting or slowing of a disease process; or
4. Preventing a disease or symptomatology.